[ad_1]
The children's hospital Federico Gómez is again an avant-garde institution [ CECILIA HIGUERA ALBARRÁN ] Federico Gómez, of the Children's Hospital of Mexico, is again at the forefront of research on the treatment of brain tumors in pediatric patients: he now has a team made in India and that is n & # 39; 39, exists nowhere else in the world. . With this equipment, the first unit of Techno Neuro-Research is created. The team, called Cytotron, arrived at the hospital in August and is currently in a phase of clinical research on degeneration (the inactivation of malignant cells that cause solid brain tumors) so that next year will reach the stage of cellular regeneration, said Dr. Pilar Dies. . Dr. Eduardo Barragán Pérez, Head of the Department of Neurology, and his colleague, Dr. Pilar Dies Suárez, Head of the Imaging Department, point out that this team is a watershed for medicine. An initial research protocol consists of treating 30 children with central nervous system problems. Once the first stage of palliative care is over, "the protocol for a more fit treatment will be open, we are doing a research protocol because we need to determine what the scope and power of the team is and then establish it as a daily therapy, "said Barragán. He mentioned the case of Lucca, a seven-year-old patient. from the children's hospital, practically from the first day of birth: he has cerebral palsy secondary to childhood, due to a choking problem at birth. His parents took him to India for a regeneration program with this team, the Cytotron. In turn, Ricardo Other, director of the Mexican company Scienta Farma and a donor of Cytotron, said the material had been delivered to the children's hospital through a loan from this company, which he could not talk about the market "because these teams will never be sold." The fundamental task, he said, is to associate with specialists such as Dr. Barragán Pérez to offer these first-line treatments. level "and, finally, what will be important at a given time is to determine the cost of such care. Fortunately, this is not the case for Mexico's Children's Hospital, which welcomes those who need it most and who are least protected; In addition to the universe of children who will benefit. To understand how Cytotron works, Dr. Dies Suárez explained that when you have an image of the brain by MRI, you can visualize the anatomical and functional part of the brain, apply the required techniques from the ones that neurologists ask, and now with Cytotron, radiofrequency pulses, it strikes the proteins of the cell and comes in two formats: degeneration and regeneration and for the moment, only the degeneration of proteins is applied solid brain tumor cells. The relevance of this team lies in the fact that brain tumors are the second leading cause of infant mortality from tumors, after leukemias – in pediatric patients – "and the truth is that the curve of leukemia with chemotherapy treatments and other new treatments they are applied has reduced mortality, however something happens with brain tumors that do not diminish, Cytotron opens a window to the possibilities open to these little children and we hope that with our research we will soon be able to benefit many patients. "
Federico Gómez of the Children's Hospital of Mexico is once again at the forefront of brain tumor treatment research in pediatric patients: he now has a team made in India and exists nowhere else in the world. the world. With this equipment, the first unit of Techno Neuro-Research is created.
The team, called Cytotron, arrived at the hospital in August and is currently in a phase of clinical research on degeneration (the inactivation of malignant cells that cause solid brain tumors) so that next year will reach the stage of cellular regeneration, said Dr. Pilar Dies. .
Dr. Eduardo Barragán Pérez, Head of the Department of Neurology, and his colleague, Dr. Pilar Dies Suárez, Head of the Imaging Department, point out that this team is a watershed for medicine.
An initial research protocol consists of treating 30 children with central nervous system problems.
Once the first stage of palliative care is over, "the protocol for a more fit treatment will be open, we are doing a research protocol, because we need to determine what is the scope and the power of the team and establish it in as a daily therapy, "said Barragán,
He mentioned the case of Lucca, a seven-year-old boy, hospitalized almost from the first day of his birth: he had cerebral palsy in the secondary child, due to a choking problem at birth. His parents took him to India for a regeneration program with this team, the Cytotron. "
In turn, Ricardo Other, director of the Mexican company Scienta Farma and donor of the Cytotron, said the material had been delivered to the children's hospital through a loan from that company, which he could not talk about the value. the market "because these teams will never be sold".
The basic task, he said, is to associate with specialists such as Dr. Barragán Pérez to offer these first-level treatments "and, finally, what will be important at a given moment is to determine Fortunately, this is not the case for the Children's Hospital of Mexico, which welcomes those who need it the most and the least protected, in addition to the world of children who benefit.
To understand how Cytotron works, Dr. Dies Suárez explained that when you have an image of the brain by MRI, you can visualize the anatomical and functional part of the brain, apply the required techniques from the ones that neurologists ask, and now with Cytotron, radiofrequency pulses, it strikes the proteins of the cell and comes in two formats: degeneration and regeneration and for the moment, only the degeneration of proteins is applied solid brain tumor cells.
The relevance of this team lies in the fact that brain tumors are the second leading cause of infant mortality from tumors, after leukemias – in pediatric patients – "and the truth is that the curve of leukemia with chemotherapy treatments and other new treatments they are applied has reduced mortality, however something happens with brain tumors that do not diminish, Cytotron opens a window to the possibilities open to these little children and we hope that with our research we will soon be able to benefit many patients. "
To print
[ad_2]
Source link
